Systemic sclerosis - Globe Thesis

Keyword [Systemic sclerosis] Result: 101 - 120 \| Page: 6 of 9
101.	Associations Between Vitamin D Receptor Gene Polymorphisms And Systemic Sclerosis
102.	The Incidence And Risk Factors Of Tuberculosis In Connective Tissue Disease :A Meta-analysis
103.	The Role Of Macrophage Migration Inhibitory Factor(MIF) On Differentiation Of Pericyte In The Rabbit Model Of Systemic Sclerosis-associated Pulmonary Hypertension
104.	Efficacy Of Mycophenolate Mofetil For The Treatment Of Systemic Sclerosis Related Interstitial Lung Disease:A Meta-Analysis
105.	Role Of HIF-1α In The Regulation Microvascular Pericyte Differentiation Of Systemic Sclerosis In Rabbits
106.	Progranulin Promotes Bleomycin-induced Skin Sclerosis By Enhancing TGF-β/Smad3 Signaling Through Up-regulation Of TGF-β Type Ⅰ Receptor
107.	The Expression And Clinical Significance Of Annexin A2 In Patients With Systemic Sclerosis
108.	A Retrospective Case-control Study On The Relationship Between Autoantibody Anti-Scl-70 And Clinical Features Of Systemic Sclerosis
109.	Risk Factors For Pulmonary Arterial Hypertension In Patients With Systemic Sclerosis:A Meta-analysis
110.	Clinical Study Of Anti-Ro52 Antibody And Connective Tissue Disease-related Interstitial Lung Disease
111.	Peripheral Blood Biomarkers In Systemic Sclerosis Associated With Interstitial Lung Diseases
112.	The Clinical Analysis Of 47 Cases Of Systemic Sclerosis
113.	The Study On The Mechanism Of Asiaticoside On Cellular Immunity And Fibrosis In Systemic Sclerosis
114.	Effect Of Huoxuehuayu Decoction On NailFold Microcirculation In Patients With Systemic Sclerosis
115.	The Effect Of Thalidomide On Inflammation And Fibrosis In Mice With Systemic Sclerosis
116.	Research On TCM Syndrome Law Of Systemic Sclerosis
117.	Single nucleotide polymorphisms (SNPs) associated with TGF-beta pathway and their significance in systemic sclerosis - A multilevel analysis
118.	Functional characterization of systemic sclerosis transcriptome
119.	From mesenchymal stem cell therapy to discovery of drug therapy for systemic sclerosis
120.	Biopsychosocial pathways of pain in patients with systemic sclerosis
<<First <Prev Next> Last>> Jump to